Holen Sie sich die Stockscreener-App
3.8283
0.82%
0.0383
Schlusskurs vom Vortag:
$3.79
Offen:
$3.79
24-Stunden-Volumen:
2.75M
Relative Volume:
0.61
Marktkapitalisierung:
$1.39B
Einnahmen:
$4.09M
Nettoeinkommen (Verlust:
$-660.15M
KGV:
-1.6607
EPS:
-2.3053
Netto-Cashflow:
$-117.10M
1W Leistung:
+12.38%
1M Leistung:
+12.71%
6M Leistung:
-30.15%
1J Leistung:
+191.68%
1-Tages-Spanne:
$3.77
$3.97
1-Wochen-Bereich:
$3.45
$3.97
52-Wochen-Spanne:
$1.15
$6.75
Ataibeckley Inc Stock (ATAI) Company Profile
Firmenname
Ataibeckley Inc
Sektor
Branche
Telefon
49 89 2153 9035
Adresse
PROF. J.H. BAVINCKLAAN 7, AMSTELVEEN
Compare ATAI vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
3.825 | 1.38B | 4.09M | -660.15M | -117.10M | -2.3053 |
VRTX
Vertex Pharmaceuticals Inc
|
433.89 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.12 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
747.85 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.40 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.62 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | Deutsche Bank | Buy |
| 2026-01-20 | Eingeleitet | Guggenheim | Buy |
| 2025-10-13 | Eingeleitet | Needham | Buy |
| 2025-07-29 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-18 | Bestätigt | H.C. Wainwright | Buy |
| 2024-04-03 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-11-01 | Eingeleitet | Loop Capital | Buy |
| 2021-11-30 | Eingeleitet | Maxim Group | Buy |
| 2021-11-11 | Eingeleitet | ROTH Capital | Buy |
| 2021-10-18 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-09-01 | Eingeleitet | Jefferies | Buy |
| 2021-07-13 | Eingeleitet | Berenberg | Buy |
| 2021-07-13 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-13 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2021-07-13 | Eingeleitet | Citigroup | Buy |
| 2021-07-13 | Eingeleitet | Cowen | Outperform |
| 2021-07-13 | Eingeleitet | Credit Suisse | Outperform |
| 2021-07-13 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Ataibeckley Inc Aktie (ATAI) Neueste Nachrichten
Why AtaiBeckley (ATAI) Is Up 13.1% After Deutsche Bank Highlights Its Post-Merger Pipeline Potential - simplywall.st
AtaiBeckley Inc. (B72.DE) - Yahoo! Finance Canada
ATAI Stock Price, Quote & Chart | ATAIBECKLEY INC (NASDAQ:ATAI) - ChartMill
Deutsche Bank initiates bullish coverage of psychedelics company AtaiBeckley - Mugglehead Magazine
AtaiBeckley Is Said to Explore Options for Main Psychedelic Drug - MSN
AtaiBeckley Inc (ATAI) Stock Price Quote Today & Current Price Chart - Capital.com
Over-the-top psychedelic promos could undermine the field’s drug development efforts - statnews.com
AtaiBeckley Inc (ATAI) Stock Price Quote Today & Current Price Chart | Capital.com Australia - Capital.com
Is Ataibeckley Inc (ATAI) looking to sell its flagship psychedelic drug candidate BPL-003? - MSN
ATAI Technical Analysis | Trend, Signals & Chart Patterns | ATAIBECKLEY INC (NASDAQ:ATAI) - ChartMill
Is It Time To Reassess AtaiBeckley (ATAI) After Its Recent Share Price Slide? - simplywall.st
AtaiBeckley Weighs BPL-003 Deal After Strong Phase 2a And FDA Support - Yahoo Finance
Is Psychedelic Nasal Spray Data And Index Inclusion Altering The Investment Case For AtaiBeckley (ATAI)? - simplywall.st
Deutsche Bank initiates coverage of AtaiBeckley (ATAI) with buy recommendation - MSN
AtaiBeckley Inc. Trade Ideas — TRADEGATE:B72 - TradingView
AtaiBeckley awarded ‘Buy’ rating in initial coverage from Deutsche Bank analysts - Yahoo! Finance Canada
AtaiBeckley initiated with a Buy at Deutsche Bank - TipRanks
Deutsche Bank Initiates AtaiBeckley at Buy With $12 Price Target - MarketScreener
Deutsche Bank initiates Atai Life Sciences stock at buy on psychedelic therapy potential - Investing.com India
Deutsche Bank Initiates AtaiBeckley(ATAI.US) With Buy Rating, Announces Target Price $12 - Moomoo
Deutsche Bank initiates Atai Life Sciences stock at buy on psychedelic therapy potential By Investing.com - Investing.com South Africa
AtaiBeckley sees promising mid-stage results for psychedelic antidepressant - MSN
H.C. Wainwright Bullish on AtaiBeckley (ATAI) - Insider Monkey
B72 Stock Price and Chart — TRADEGATE:B72 - TradingView
A Look At AtaiBeckley (ATAI) Valuation After Index Inclusions And Positive BPL-003 Phase 2a Results - simplywall.st
Is AtaiBeckley Inc (ATAI) Looking to Sell Its Flagship Psychedelic Drug Candidate BPL-003? - Insider Monkey
AtaiBeckley added to S&P Total Market, CRSP benchmark indices By Investing.com - Investing.com Australia
Ataibeckley Insider Sold Shares Worth $355,000, According to a Recent SEC Filing - MarketScreener
5 Best Psychedelic Stocks to Buy in 2026 - insidermonkey.com
AtaiBeckley chief medical officer Craig Kevin James sells $355,000 in stock - Investing.com
AtaiBeckley chief medical officer Craig Kevin James sells $355,000 in stock By Investing.com - Investing.com South Africa
Small cap wrap: Fox Tungsten, AtaiBeckley, Ocean Power Technologies, Abacus Global Management… - Proactive Investors
AtaiBeckley added to major US indices, increasing reach among passive investors - Yahoo Finance
AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst - Bitget
AtaiBeckley added to S&P Total Market, CRSP benchmark indices - Investing.com
AtaiBeckley Inc. Added to S&P Total Market Index and CRSP U.S. Benchmark Indices, Enhancing Market Presence and Driving Index Fund Position-Building - quiverquant.com
AtaiBeckley weighing options for lead psychedelic therapy: Bloomberg - MSN
AtaiBeckley Inc.(NasdaqGM: ATAI) added to S&P TMI Index - marketscreener.com
[144] Atai Beckley N.V. SEC Filing - Stock Titan
AtaiBeckley Advances BPL-003 Program As Beckley Psytech Deal Closes - simplywall.st
AtaiBeckley: BPL-003 Phase 3 Momentum Keeps Me Bullish (NASDAQ:ATAI) - Seeking Alpha
Assessing AtaiBeckley (ATAI) Valuation As Strong Long Term Returns Contrast With Heavy Losses - Yahoo Finance
AtaiBeckley: Advancing BPL-003 Into Pivotal Phase 3 With Strategic Optionality and Strong Cash Runway Supporting a Buy Rating - TipRanks
H.C. Wainwright reiterates atai Life Sciences stock rating at buy By Investing.com - Investing.com India
Finanzdaten der Ataibeckley Inc-Aktie (ATAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.90%
1.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):